Reed Vaughn Tuckson Net Worth

The estimated Net Worth of Reed Vaughn Tuckson is at least $4.9 Million dollars as of 4 June 2018. Reed Tuckson owns over 2,284 units of Unitedhealth Inc stock worth over $4,901,412 and over the last 14 years Reed sold UNH stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Reed Tuckson UNH stock SEC Form 4 insiders trading

Reed has made over 3 trades of the Unitedhealth Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Reed exercised 2,284 units of UNH stock worth $1,346,989 on 4 June 2018.

The largest trade Reed's ever made was exercising 290,000 units of Unitedhealth Inc stock on 9 February 2012 worth over $11,637,700. On average, Reed trades about 8,822 units every 52 days since 2011. As of 4 June 2018 Reed still owns at least 8,311 units of Unitedhealth Inc stock.

You can see the complete history of Reed Tuckson stock trades at the bottom of the page.

What's Reed Tuckson's mailing address?

Reed's mailing address filed with the SEC is C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY, CA, 94063.

Insiders trading at Unitedhealth Inc

Over the last 21 years, insiders at Unitedhealth Inc have traded over $719,092,689 worth of Unitedhealth Inc stock and bought 8,476,440 units worth $479,120,597 . The most active insiders traders include Stephen J Hemsley, Edson De Godoy Bueno, and Richard T Burke. On average, Unitedhealth Inc executives and independent directors trade stock every 16 days with the average trade being worth of $49,378,588. The most recent stock trade was executed by Erin Mc Sweeney on 18 July 2024, trading 1,500 units of UNH stock currently worth $868,545.

What does Unitedhealth Inc do?

UnitedHealth Group Incorporated is a for-profit American multinational managed healthcare and insurance company based in Minnetonka, Minnesota.

Complete history of Reed Tuckson stock trades at Adverum Biotechnologies Inc, CTI BioPharma Corp, Henry Schein, and Unitedhealth Inc

Unitedhealth Inc executives and stock owners

Unitedhealth Inc executives and other stock owners filed with the SEC include:

• David Wichmann,
  Chief Executive Officer
• John Rex,
  Chief Financial Officer, Executive Vice President
• Dirk McMahon,
  Chief Executive Officer - UnitedHealthcare
• Stephen Hemsley,
  Non-Executive Chairman of the Board
• Marianne Short,
  Executive Vice President, Chief Legal Officer
• D. Ellen Wilson,
  Executive Vice President - Human Capital
• Patricia L. Lewis,
  Exec. VP & Chief HR Officer
• Dirk C. McMahon,
  Pres & COO
• John F. Rex,
  Exec. VP & CFO
• Sir Andrew Philip Witty,
  CEO & Director
• Richard Burke,
  Lead Independent Director
• Glenn Renwick,
  Independent Director
• William Ballard,
  Independent Director
• Gail Wilensky,
  Independent Director
• Michele Hooper,
  Independent Director
• Timothy Flynn,
  Independent Director
• Valerie Montgomery Rice,
  Independent Director
• F. William McNabb,
  Independent Director
• John Noseworthy,
  Independent Director
• Frances Jacobs,
  IR Contact Officer
• Thomas Roos,
  Senior Vice President, Chief Accounting Officer
• Terry M. Clark,
  Chief Marketing Officer & Sr. VP
• James T. Barry Jr.,
  Director of Sales for Western Pennsylvania
• Jennifer Mound Smoter,
  Sr. VP & Chief Communications Officer
• Dannette L. Smith,
  Sec. to the Board & Sr. Deputy Gen. Counsel
• Philip G.J. McKoy,
  Chief Information Officer
• Thomas Edward Roos,
  Sr. VP & Chief Accounting Officer
• Paul R Garcia,
  Director
• Andrew Witty,
  CEO, UHG
• Edson De Godoy Bueno,
  Director
• Robert J Darretta,
  Director
• Rodger A Lawson,
  Director
• Kenneth Irwin Shine,
  Director
• Larry C Renfro,
  EVP, UHG & CEO, Ovations
• Steven H Nelson,
  EVP & CEO, UnitedHealthcare
• Brian R Thompson,
  CEO, UnitedHealthcare
• William A Munsell,
  CEO, Specialized Care Services
• Thomas H Kean,
  Director
• William W Mcguire,
  Chairman & CEO
• Mitchell Eliot Zamoff,
  EVP and General Counsel
• Anthony Welters,
  EVP & Pres Publc & Sr Mkts Grp
• Richard H Anderson,
  CEO, Ingenix
• Tracy L Bahl,
  CEO, Uniprise, Inc.
• Richard N Baer,
  EVP & Chief Legal Officer
• Patrick J Erlandson,
  Chief Financial Officer
• Reed Vaughn Tuckson,
  EVP & Chief of Medical Affairs
• Thomas L Strickland,
  EVP & Chief Legal Officer
• William G Spears,
  Director
• James A /Dc/ Johnson,
  Director
• Mary Oneil Mundinger,
  Director
• George Lawrence Iii Mikan,
  EVP and CFO
• Gail Boudreaux,
  EVP & Pres, UnitedHealthcare
• Robert J Sheehy,
  CEO, UnitedHealthcare
• Robert L Ryan,
  Director
• Christopher James Walsh,
  EVP and General Counsel
• Forrest Gregory Burke,
  Acting General Counsel
• R Channing Wheeler,
  CEO, Uniprise, Inc.
• Douglas W Leatherdale,
  Director
• Eric S Rangen,
  Sr VP & Chief Acctg Officer
• Donna E Shalala,
  Director
• David J Lubben,
  Secretary and General Counsel
• Lois E Quam,
  CEO, Ovations, Inc.
• Lori Sweere,
  EVP, Human Capital
• Patricia L Lewis,
  EVP and Chief HR Officer
• Kristen Gil,
  Director
• Rupert M Bondy,
  EVP & Chief Legal Officer
• Erin Mc Sweeney,
  EVP & Chief People Officer
• Charles D. Baker,
  Director
• Christopher R Zaetta,
  EVP & Chief Legal Officer
• Heather Cianfrocco,
  Chief Executive Officer, Optum